Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 7 (3), 191-201

PI3K Delta and PI3K Gamma: Partners in Crime in Inflammation in Rheumatoid Arthritis and Beyond?

Affiliations
Review

PI3K Delta and PI3K Gamma: Partners in Crime in Inflammation in Rheumatoid Arthritis and Beyond?

Christian Rommel et al. Nat Rev Immunol.

Abstract

Dysregulated signal transduction in innate and adaptive immune cells is known to be associated with the development of various autoimmune and inflammatory diseases. Consequently, targeting intracellular signalling of the pro-inflammatory cytokine network heralds hope for the next generation of anti-inflammatory drugs. Phosphoinositide 3-kinases (PI3Ks) generate lipid-based second messengers that control an array of intracellular signalling pathways that are known to have important roles in leukocytes. In light of the recent progress in the development of selective PI3K inhibitors, and the beneficial effects of these inhibitors in models of acute and chronic inflammatory disorders, we discuss the therapeutic potential of blocking PI3K isoforms for the treatment of rheumatoid arthritis and other immune-mediated diseases.

Similar articles

See all similar articles

Cited by 138 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback